key: cord-0882288-8r5v5bt3
authors: Xu, Hui; Xie, Cheng-yuan; Li, Pei-hong; Ji, Zhong-liang; Sun, Jiu-feng; Hu, Bei; Li, Xin; Fang, Ming
title: Demographic, Virological Characteristics and Prognosis of Asymptomatic COVID-19 Patients in South China
date: 2022-01-28
journal: Front Med (Lausanne)
DOI: 10.3389/fmed.2022.830942
sha: 97dac4f666ae3b14962ee44d6ab91de1747ef9e3
doc_id: 882288
cord_uid: 8r5v5bt3

BACKGROUND: Asymptomatic transmission is a major concern for SARS-CoV-2 community spread; however, little information is available on demographic, virological characteristics and prognosis of asymptomatic cases. METHODS: All COVID-19 patients hospitalized in Guangdong Province from September 1, 2020 to February 28, 2021, were included and were divided into asymptomatic and symptomaticgroup. The source country of all patients, clinical laboratory test results, the genotype of virus and the time of SARS-CoV-2 RNA turning negative or hospitalization were confirmed. RESULTS: Total 233 patients from 57 different countries or regions were included, with 83 (35.6%) asymptomatic and 150 (64.4%) symptomatic patients. Asymptomatic cases were younger (P = 0.019), lower rate in comorbidities (P = 0.021) such as hypertension (P = 0.083) and chronic liver disease (P = 0.045), lower PCT (P = 0.021), DDI (P < 0.001) and ALT (P = 0.029), but higher WBC count (P = 0.002) and lymphocyte (P = 0.011) than symptomatic patients. As for SARS-CoV-2 subtypes, patients infected with B.1.1 (53.8%), B.1.351 (81.8%) and B.1.524 (60%) are mainly asymptomatic, while infected with B, B.1, B.1.1.63, B.1.1.7, B.1.36, B.1.36.1, B.1.36.16, B.1.5 and B.6 were inclined to be symptomatic. Patients infected with variant B.1.351 and B.1.524 spent longer time in SARS-CoV-2 RNA turn negative (26 days, P = 0.085; 41 days, P = 0.007) and hospitalization (28 days, P = 0.085; 43 days, P = 0.004). CONCLUSIONS: The asymptomatic cases are prone to develop in patients with younger age, less comorbidities andinfected with B.1.1 and B.1.524 variants. More attention should be paid for lineage B.1.524 because it can significantly prolong the SARS-CoV-2 RNA negative conversion time and hospitalization in infected cases.

The Coronavirus disease 2019 (COVID- 19) is still a worldwide pandemic. Recently, there have been many clusters of cases in China, such as Guangzhou, Nanjing, Heilongjiang, Shaanxi, Chongqing and Jiangsu, among which asymptomatic cases account for a large proportion. "Asymptomatic" is defined as an individual with laboratory-confirmed SARS-CoV-2 infection but without symptoms throughout their entire course of infection, or after 14 days follow-up (1) . Currently asymptomatic transmission is a major concern for SARS-CoV-2 community spread (1) . Some studies indicate that the asymptomatic persons can indeed transmit SARS-CoV-2 to others which cause the rapid spread of the virus (2) . Moreover, the asymptomatic persons are likely to have far more interaction with others than those who have symptoms (2) . There are a large number of asymptomatic infections in the world. Through an analysis of more than 350 clinical studies, 42.8% of cases exhibited no symptoms, a group comprising both asymptomatic and presymptomatic infections, and truly asymptomatic was 35.1% (3) . A study has found that asymptomatic patients were younger (37 years vs. 56 years, P < 0.001) and had a higher proportion of women (66.7 vs. 31.0%, P = 0.002) (1) . And the findings of a study highlight that females and children were the predominant groups without symptoms of COVID-19 (4) . Due to August 31 st , 2020, since when asymptomatic infection of COVID-19 draw our attention, 1,740 cases of COVID-19 infection were diagnosed in Guangdong Province according to news released from Guangdong Provincial Central for Disease Control and Prevention (CDC), and the very first COVID-19 case reported in Guangdong Province was back on January 19 th , 2020, however, the subtype of virus has not been systematically analyzed and no information was reported. Little information was known about asymptomatic patients and their virus genotype, have there been any differences between symptomatic and asymptomatic cases except for clinical symptoms? Therefore, we intend to compare asymptomatic cases with symptomatic cases, so as to find out the prone population of asymptomatic casesand more information about the demographic characteristics of them.

SARS-CoV-2, like other RNA viruses, is prone to genetic evolution while adapting to their new human hosts with the development of mutations over time, resulting in the emergence of multiple variants that may have different characteristics compared to its ancestral strains (5) . As Rambaut et al. (6) proposed, we used PANGOLIN classification to categorize virus variants that mentioned in the study for better understanding. For example, SARS-CoV-2 Delta lineages (B.1.617.2) had led to a new wave of outbreak in Guangdong Province lately, which was shorter in incubation period and more virulent (7) . According to its transmissibility and virulence, WHO classified SARS-CoV-2 variants into Variants of Concern (VOC) and Variants of Interest (VOI) (8) . VOC was defined as a variant which increases in transmissibility, virulence, and decrease in effectiveness of available diagnostics, vaccines, and therapeutics. However, little information is available on whether there is a difference between asymptomatic and symptomatic patients in terms of different SARS-CoV-2 subtypes. The aim of this article is to explore whether there is a significant difference in the occurrence and outcome of asymptomatic persons caused by VOC and VOI infection, and if there are any transmissible and virulent variants not included in VOC that needed to be paid attention to by analyzing the statistical results. We used statistical methods to conduct a retrospective cohort study on 233 confirmed cases whose virus genotypes were known by RNA detection in Guangdong Province of China from September 2020 to February 2021. According to some studies, the ability of asymptomatic infections to spread the virus is not low, and these patients are likely to cause a new round of outbreaks, so finding asymptomatic infections is the key point for early prevention and control of COVID-19 worldwide (9) . Meanwhile asymptomatic transmission of SARS-CoV-2 is the Achille's heel of Covid-19 pandemic control through the public health strategies we have currently deployed (10) . So we should focus attention and resources on the variants with the highest public health implications to develop more effective immunization strategies.

A retrospective cohort study had been carried out at 32 designated hospitals in Guangdong Province. Patients diagnosed with COVID-19 from September 1, 2020 to February 28, 2021 and the genotype of virus confirmed through nucleic acid and gene sequencing technology were included in this study. In order to prevent the spread of COVID-19, the Guangdong COVID-19 Prevention and Control Headquarters had been set up in Guangdong Province. Authorized by the Guangdong Provincial Health Commission, an electronic medical information reporting system (E-System) was built to collect the entire provincial medical data.

Patients confirmed with SARS-CoV-2 infection during September 1 st , 2020 to February 28 th , 2021 been tested for subtype of virus were enrolled in this study, and then went through 14-day follow-up after they had reached criteria of discharge (see below in definitions part). Patients were divided into two groups, the asymptomatic group and the symptomatic group, based on whether any clinical manifestations were shown during whole hospitalization and 14-day follow-up. Data of patient's source country, demography like gender and age, medical history, laboratory tests like blood routine [white blood count (WBC), neutrophils percentage (NE%), lymphocytes percentage (LYMPH%)], inflammation factors [e.g.,: procalcitonin (PCT) and erythrocyte sedimentation rate (ESR)], index of organ function [e.g.,: aspartate transaminase (AST), alanine transaminase (ALT), creatine kinase (CK) and D-dimer], and time point of clinical course like the time patients been tested positive for SARS-CoV-2 RNA, the time they turned negative, the admission time and the discharge time, were extracted from E-system.

For the purpose of ensuring the accuracy and reliability, all the patient's data were reviewed by at least two researchers, and a third researcher adjudicated differences in interpretation if applicable.

The method to confirm infection of SARS-CoV-2: a cotton swab was insertedinto patient's pharynx or nasal cavity, then rotated to scrape secreta from mucous membrane and stayed for a few second to obtain a sample (11) . Nucleic acid extraction reagent was addedin the sample to destroy the virus and release the nucleic acid, through Reverse transcription Technology (RT), the viral RNA was "reversed" into a specific DNA, that was, cDNA (because the viral RNAstructure was unstable, it was more convenient to convert viral RNA into stable cDNA for detection). And in the process, reverse transcriptase in a nucleic acid test kit played an important role. Reverse transcriptase used dNTP as the substrate, RNA as the template, tRNA (mainly tRNA tryptophan) as the primer, on the 3 ′ -end of tRNA, in the direction of 5 ′ → 3 ′ , to synthesize a cDNA single strand complementary to RNA template. Then, under the action of reverse transcriptase, the RNA strand was hydrolyzed, and a second DNA strand was synthesized using cDNA as a template. And at this point, the RNA-guided DNA synthesis process was completed. Once reverse transcription was done, cDNA was continuously made in exponential growth with use of PCR. When cDNA was amplified, something called fluorescent-labeled hydrolytic probe in the kit worked at the same time. A fluorescent signal that increased a little bit with each cDNA amplification was emit by the probe, and an increased Ct value of the fluorescent signal was recorded by the PCR detector. Then, the detection results were analyzed according to the Ct values recorded by the detector. Ideally, if there was novel coronavirus in the sample, the Ct values recorded by the detector would form a gradually rising S-shaped curve after the cDNA had been amplified for the number of times booked, and the test result would be positive. If there was no similar S-shaped curve, the test result was negative (12) (13) (14) .

The method to determine the genotype of infected virus: At first, samples were collected from which virus RNA were extracted, which was consistent with the previous introduction. Next, in order to facilitate detection, it was also needed to transcribe the viral RNA reverse into cDNA. Then, the complete DNA to be tested were mainly broken into 200-500 bp long sequence fragments, and different connectors were added at both ends of these small fragments to construct a single stranded DNA library. When the library was built, the DNA in these libraries would be randomly attached to the channel on the surface of flow cell when passing through the flow cell. There were 8 DNA splices on the surface of each channel, which could support each other in the process of PCR. As for bridge PCR, the connector fixed on the surface of flow cell was used as the template for bridge amplification. After continuous amplification and denaturation cycle, each DNA fragment would finally be concentrated into bundles at their respective positions. Each bundle contained many copies of a single DNA template. The purpose of this process was to amplify the signal strength of the base to meet the signal requirements for sequencing. The sequencing method adopted the method of synthesis and sequencing. DNA polymerase, linker primer and 4 dNTP with base specific fluorescent label were added to the reaction system at the same time (as Sanger sequencing method). The 3 ′ -Oh of these dNTP was protected by chemical methods, so only one dNTP could be added at a time. After dNTP was added to the synthetic chain, all unused free dNTP and DNA polymerase would be washed off. Then, the buffer required to excite fluorescence was added, the fluorescence signal was excited by laser, and the fluorescence signal was recorded by optical equipment. Finally, the optical signal was transformed into sequencing base by computer analysis. Finally, the measured DNA sequence was compared with the existing database and a test report was issued to know the genotype of the infected virus (15, 16) .

Asymptomatic patient refers to individuals with laboratoryconfirmed SARS-CoV-2 infection but without symptoms throughout their entire course of infection, or after 14 days of follow up (1).

The criteria of discharge: (1) body temperature reached normal for more than 3 days; (2) respiratory symptoms improved significantly; (3) improvement in lung computed tomography scans (CT); (4) negative SARS-CoV-2 RNA tests for 2 consecutive times (24-h interval) (11) .

The criteria for nucleic acid turning negative were as follows: the patient's symptoms had basically disappeared, CT examination showed that the lung lesions had been basically absorbed, and more than two consecutive (intervals of more than 24 h) nucleic acid tests were negative, And the interval between positive nucleic acid test and consecutive (intervals of more than 24 h) nucleic acid tests was time of SARS-CoV-2 RNA turning negative (17) . Time of hospitalization refers to interval between admission and discharge (18) .

WHO has been constantly monitoring and assessing the variantsofSRAS-CoV-2, and variants were categorized as Variants of Interest (VOI) and Variants of Concern (VOC) in accordance to its transmissibility and toxicity (8) .

VOI are identified as SARS-CoV-2 variants with genetic changes that are predicted or known to affect virus characteristics such as transmissibility, disease severity, immune escape, diagnostic or therapeutic escape and identified to cause significant community transmission or multiple COVID-19 clusters, in multiple countries with increasing relative prevalence alongside increasing number of cases over time, or other apparent epidemiological impacts to suggest an emerging risk to global public health. VOI mainly include lineage B. 

All data were analyzed by SPSS26.0 software. Exploratory analysis was used for normality test and P < 0.05 suggests that the data did not obey the normal distribution. The categorical variables were expressed in frequency (percentage) and Chi-square test or Fisher's exact tests were used for comparison between the two groups (the asymptomatic and the symptomatic) and two-sided p of < 0.1 was considered statistically significant. The normal distribution of continuous variables was expressed as mean ± standard deviation, and the skew distribution was expressed as median with interquartile range (IQR). Independent sample Ttest or non-parametric test was used, and two-sided p of < 0.1 was considered statistically significant.

As the Table 1 shown, a total of 233 patients diagnosed with COVID-19 were enrolled in this study, composed of 83 asymptomatic patients and 150 symptomatic patients. Eighty three asymptomatic patients had younger average age (32.71 ± 12.17 vs. 36.73 ± 12.55, P = 0.019), less comorbidities (8.4 vs. 20.0%, P = 0.021) such as hypertension (2.4 vs. 9.3%, P = 0.021) and chronic liver disease (1.2 vs. 8.7%, P = 0.045), but higher in chronic lung disease (4.8 vs. 0.7%, P = 0.056) when compared to symptomatic group. There was no significant difference in sex, comorbidity of cardiovascular, cerebrovascular, chronic kidney diseases and the time of SARS-CoV-2 RNA turning negative between the two groups.

Patients tested positive for SARS-CoV-2 RNA shall be admitted to designated hospital as soon as possible, and the day they got admission, laboratory tests as blood routine, inflammation factors, index of organ function level should be tested immediately for indication of disease severity and guidance of therapy. When compared to the symptomatic group, the asymptomatic group was lower in NE% (55.65 vs. 60.4%, P = 0.019), PCT (0.055 vs. 0.108, P = 0.021), ALT (21 vs. 23.53, P = 0.029), CK (53.5 vs. 71, P = 0.025) and DDI (0.22 vs. 85, P < 0.001), but has higher WBC count (6.155 vs. 5.280, P = 0.002) and LYMPH% (31.3% vs. 27.95, P = 0.011) ( Table 1) .

Of the 223 COVID-19 patients in the study, 10 were infected with virus genotypes from PANGOLIN cluster A, 222 were infected with virus genotypes from PANGOLIN B cluster and 1 was infected with virus genotype of PANGOLIN C cluster. Therefore, virus genotypes from PANGOLIN B cluster accounted for more than 95% of the total and were the focus of this study ( Table 1) .

As Figure 1 shown, the patients were infected with 63 different virus genotypes, of which 4 were from PANGOLIN A concentrated in B, B,1, B,1,1,  B,1,1,63, B,1,1,7, B.1.351, B.1,36, B.1.36.1, B.1.36.16, B.15 

As Figure 2 shown, 233 COVID-19 patients in this study were from 57 different countries or regions. And the patients were mainly associated with Russia, France, Philippines, Ghana, Kuwait, Malaysia, United State of America (USA), Bangladesh, Myanmar, South Africa, Nigeria, Hong Kong (Chinese special administrative region), Indonesia and United Kingdom (UK). Of the patients from Russia, Ghana, Myanmar, Indonesia and especially South Africa, the asymptomatic group were the majority. While of the patients from France, Philippines, Kuwait, Malaysia, USA, Bangladesh, Nigeria, and Hong Kong, the symptomatic were the majority.

As 

Asymptomatic cases of COVID-19 are more often been reported over countries and regions, the proportion of asymptomatic cases out of positive SARS-CoV-2 RNA infectors could range from 4 to 91.7% quoted from related studies (1, 9, 19) . These studies reported that asymptomatic cases were younger and had a higher proportion of women (see previous), lower in monocytes and alanine aminotransferase compared to symptomatic cases. The prevalence of asymptomatic case reported from those studies varies a lot, also lack of clinical outcome and message of virus subtype. To verify the prevalence and characteristics of asymptomatic cases, this study was conducted and to further explore the impact of different virus subtype could do to clinical manifestation of COVID-19 patients.

The proportion of asymptomatic cases in this study was 35.6%. Previous reports had suggested that asymptomatic cases can also be communicable (20) (21) (22) (23) and more easily to cause popular transmission in community than symptomatic cases since the public are much alert to people who have symptoms like cough, fever or etc. that rather attract attention and have been detected earlier. But patients with no symptom manifested could relax the guard instead. Thus, recognizing asymptomatic patient at an early stage and taking action to it plays an important role in prevention and control of COVID-19 nowadays.

Our data revealed that asymptomatic patients comprised majorly of Mongolian, and were younger, had lower rate in comorbidities such as hypertension and chronic liver disease. As for laboratory test, we discovered that asymptomatic patients were higher in WBC count and lymphocyte, but lower in pct, ALT and DDI compared to symptomatic patients. The results indicated that younger patients with less comorbidities prone to FIGURE 2 | Number of patients originated from different countries or regions between asymptomatic and symptomatic groups. The X axis refers to number of patients that come from different countries or regions; the Y axis refers to the different countries or regions that involved in this study. Patients originate from Russia, Ghana, Myanmar, Indonesia and especially South Africa was dominated by asymptomatic cases. While patients originate from France, Philippines, Kuwait, Malaysia, America, Bangladesh, Nigeria, and HK-China were dominated by symptomatic cases. Frontiers in Medicine | www.frontiersin.org be asymptomatic when infected with novel coronavirus, due to their stronger immune function, they had milder inflammation response and less damage to organ function. Qin, Wang, Qu et al. (24) (25) (26) suggested that decreased lymphocyte account indicated a severe phenotype of inflammation or disease which leads to longer hospitalization time. And there are studies noticed that higher D-Dimer level has a positive relationship to severity of COVID-19 disease and hospitalization (26) (27) (28) . Laboratory tests in our study recommend that inflammatory response was milder in asymptomatic patients and less in liver damage that consist with lower comorbidity especially chronic liver disease mentioned before, which could explain the slight clinical symptoms.

Though some studies reported higher proportion of female in asymptomatic cases (1, 4) , no significant differences in gender between symptomatic and asymptomatic group were observed in this study, further study of larger sample size was needed for verification. Nevertheless, no significant difference shown in time of positive SARS-CoV-2 RNA turn negative between asymptomatic and symptomatic patients, this reminds a similar viral shedding between the two groups, and there is report suggested viral load between symptomatic and asymptomatic patients had no difference neither (29) . But what makes this significant difference in clinical features between symptomatic and asymptomatic patients left in a mystery, and we wonder whether different viral subtype could be relevant.

SARS-CoV-2 RNA is easily getting mutate during its duplication, and patients infected with different variants of coronavirus could be various in pattern of clinical manifestation, course of disease and prognosis, which brings huge difficulty to diagnosis, therapy and prevention in clinics.

We managed to gain the 233 patient's nasopharyngeal or oral swab, those specimens went through rt-PCR test to clear its variants that got infected, and clarified with PANGOLIN lineage, among which, only 10 patients were infected with PANGOLIN A cluster, 1 patient was infected with PANGOLIN C cluster, and the other 222 patients were infected with PANGOLIN B cluster. Most of the patients enrolled in this study were infected with variants from PANGOLIN B cluster, and based on the difference of spike mutation of SRAS-CoV-2, PANGOLIN B cluster was further divided into different variants.

From our data, the variants patients got infected majorly concentrated on lineage B, B. ) were symptomatic, had higher comorbidity rate and ALT level, which comply with common know. However, patients infected with B.1.351 were mainly asymptomatic (81.8%), and had higher level of lymphocyte account, ALT and DDI, spent longer time in SARS-CoV-2 RNA turning negative. The elevated ALT and DDI level could be explained by its stronger toxicity, but the high asymptomatic ratio, which disobeyed its characteristics, bring us confusion. With the increasing number of COVID-19 patients, the public's alert to this pandemic is growing, and detection of COVID-19 is more intensive and rigorous. For example, people who take public transportations shall go through examinations by local staff from Centers for Disease Control (CDC), and those had clinical symptoms such as fever, cough or etc. are much more difficult to pass these examinations, infected people with milder symptoms or even lack of them are more possible to escape and travel to other country or region, and this may explain why patients infected with B.1.351 enrolled in this study are majorly asymptomatic.

When compared to the total, we observed that 60% patients infected with lineage B.1.524 were asymptomatic, they hada longer time in SARS-CoV-2 RNA turning negative and hospitalization, even longer than VOC group (B.1.1.7 + B.1.351), prompted B.1.524 has longer viral shedding period. There is a study reported that SARS-CoV-2 from third wave clusters in Malaysia was dominant by local lineage B.1.524 (30) . The long viral shedding time in lineage B.1.524 madeit longer to turn SARS-CoV-2 RNA negative, indicated a wilder time range to cause transmission especially from asymptomatic patients. Asymptomatic infection would decrease our alertness and more easily to spread in public, difficulties in epidemic prevention would increase and more medical resource would be consumed. For symptomatic patients infected with B.1.524, the long time in SARS-CoV-2 RNA turning negative and hospitalization indicate greater viral load that could be much burden to patient's organ function and aggravate poor prognosis.

Lineage B.1.524 shall attract more concentration, nonetheless that this study was lack of enough sample and data to analyze the transmissibility and toxicity of lineage B.1.524, thus further multi-center study was expected to be conducted.

There are limitations in our study. We collected data of SARS-CoV-2 RNA turn negative time and speculate its similar viral shedding time among different variants, but no specimens had been tested for viral load at patients got admission, and samples of variants are in deficiency. We expect to collect data of viral load, virus subtype and information of spread, analysis could be made to compare the toxicity of different variants.

In conclusion, asymptomatic cases are prone to develop in patients with younger age, comparatively good immune and organ function and less comorbidities, especially those who infected with lineage B.1.1 and B.1.524. More attention should be paid to lineage B.1.524 for it can cause poor prognosis and significantly prolong the SARS-CoV-2 RNA negative conversion time and hospitalization.

The original contributions presented in the study are included in the article/supplementary materials, further inquiries can be directed to the corresponding author/s.

The studies involving human participants were reviewed and approved by the Institutional Review Board of Guangdong Health Commission and Guangdong Provincial People's Hospital (No. GDREC2020028H). Written informed consent from the participants' legal guardian/next of kin was not required to participate in this study in accordance with the national legislation and the institutional requirements.

MF had the idea for and designed the study. HX, C-yX, P-hL, and J-fS had full access to all data in the study and took responsibility for the integrity of the data. HX, C-yX, P-hL, and Z-lJ were responsible for data collection and data analysis. MF, HX, C-yX, and P-hL contributed to writing of the report. BH and XL polished the article. All authors contributed to data acquisition and data interpretation, reviewed, and approved the final version. 

The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living systematic review

Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review

Asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis

Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)

Asymptomatic SARS-CoV-2 Carriers: a systematic review and metaanalysis

A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology

Transmission, viral kinetics and clinical characteristics of the emergent SARS

WHO. Tracking SARS-CoV-2 Variants. Available online at

A systematic review of asymptomatic infections with COVID-19

Asymptomatic transmission: the achilles' heel of current strategies to control Covid-19

Epidemiological and clinical findings of short-term recurrence of severe acute respiratory syndrome coronavirus 2 ribonucleic acid polymerase chain reaction positivity in 1282 discharged coronavirus disease 2019 cases: a multicenter, retrospective, observational study

Current methods for diagnosis of human coronaviruses: pros and cons

COVID-19 diagnosis -a review of current methods

Application of PCR in novel coronavirus nucleic acid detection

Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities

From cheek swabs to consensus sequences: an A to Z protocol for high-throughput DNA sequencing of complete human mitochondrial genomes

High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients

An analysis of factors associated with prolonged time of viral RNA turning negative in 148 patients with COVID-19

Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2

Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study

Transmission of 2019-nCoV infection from an asymptomatic contact in Germany

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the diamond princess cruise ship

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirusinfected Pneumonia in Wuhan

Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Laboratory abnormalities in patients with COVID-2019 infection

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

Emergence of B. 1524(G) SARS-CoV-2 in Malaysia during the third COVID-19 epidemic wave

We thank all designated hospitals and Yu-fei Duan, Guanxian Liu, Li Chen, Fa-bin Zhang, Hong-xiang Feng, Jie-wu Guo, Yong-jia Chen, Rui-jie Yao, Ming Li and Yong-ping Du (Health Commission of Guangdong Province) for facilitating the collection of patient's data; statistical team members Xiaoqing Lin, Min-Qing Li, Hai-dong Chen, Shu-gen Luo, Jin-hong Wang (the Rescue Team of Guangdong Provincial COVID-19 Prevention and Control Headquarters) for their dedication to data collection and verification for COVID-19 patients.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.Copyright © 2022 Xu, Xie, Li, Ji, Sun, Hu, Li and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.